… difficile, some patients become asymptomatic carriers of the organism, whereas others
contract C. difficile-associated diarrhea, which may range from mild watery diarrhea to life-…

… 85 Clostridium difficile‐associated diarrhea episodes per 1000 patients at high risk of C.
difficile … are superior to placebo or no treatment for preventing Clostridium difficile‐associated …

… Overall, the risk for development of C difficile–associated diarrhea (CDAD) within 6 weeks
of a course of antibiotics in the outpatient setting is low (6.7 cases per 100 000 exposures). …

… Up to 67% of neonates delivered in hospitals may be colonized with C. difficile, but rarely
show diarrheal symptoms. This is thought to be due to the lack of C. difficile toxin receptors in …

… C difficile–associated diarrhea … C.difficile–associated diarrhea include antibiotic therapy,
advanced age, number and severity of underlying diseases, and faulty immune response to C. …

… difficile is the leading cause of nosocomial infectious diarrhea. Hospitalized patients were
at risk of C. difficile-associated diarrhea (CDAD). However the risk factors of CDAD in patients …

… criteria: I) a change in bowel habits with three or more loose stools per day for >2 consecutive
days, and 2) a temporal association between CD toxin positivity and diarrheal symptoms. …

… This CDC report emphasized that, in the past, C. difficile-associated diarrhea (CDAD) usually
affected hospital inpatients, but now was appearing in relatively healthy adults, including …

… its presence did not correlate with the diarrheal symptoms in either inpatients or outpatients.
… for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996;22:813-8. …

… Clostridium difficile–associated diarrhea, prophylaxis The incidence of Clostridium
difficile–associated diarrhea … is approved for the treatment of CDAD in adults, and is …